LG Chem said Friday that it has launched its polynucleotide (PN)-based skin booster, HP VITARAN (export name: HP Cell VITARAN i), in Thailand, marking an expansion of its aesthetic product offerings.

The move follows the introduction of LG Chem’s dermal filler YVOIRE in 2021 and leverages the company’s direct sales network in Thailand. LG Chem said that the synergy between the two products is expected to accelerate its growth in Thailand, recognized as a high-potential market in the medical aesthetics field.

VITARAN is a skin booster medical device designed for injectable use introduced in Korea in 2023, developed through a collaboration with Korea-based regenerative medicine company BR Pharm. Unlike skin boosters approved as cosmetics, VITARAN, being a medical device, allows direct application into the skin, offering visible improvement, LG Chem said.

The product’s raw materials are sourced from BR Pharm’s trout farming facilities, certified safe by Korea’s National Institute of Fisheries Science.

Thailand, Southeast Asia’s largest aesthetic market, has seen rapid growth in non-invasive procedures. According to the Thai Society of Cosmetic Dermatology and Surgery, the market was valued at 700 billion won ($484 million) in 2023 and is projected to more than double to 1.5 trillion won by 2030.

“With increasing demand for natural skin improvement, injection-based treatments like fillers and skin boosters are gaining popularity,” an LG Chem official said. “Companies with diverse product lines that meet the needs of both consumers and physicians are well-positioned to succeed.”

In addition to YVOIRE and VITARAN, LG Chem is preparing to launch its premium filler line, Y-Solution, as part of its strategy to expand its influence in Thailand’s aesthetic market.